[Studies on antibody formation by L-asparaginase]

Temporal trends and spatial distribution of research topics in anthropogenic marine debris study: Topic modelling using latent Dirichlet allocation.

Marine pollution bulletin·2022

MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression.

Oncogene·2016

Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.

Clinical & experimental metastasis·2015

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.

European journal of gynaecological oncology·2014

Surgical treatment outcomes of serious chronic tubo-ovarian abscess: a single-center series of 20 cases.

Clinical and experimental obstetrics & gynecology·2013

Pectic polysaccharides in carrot cells growing in suspension culture.

Planta·2013

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[DDX41-mutated myeloid neoplasms].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

Rheumatology (Oxford, England)·2026

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

CNS neuroscience & therapeutics·2026

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Haematologica·2026

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Haematologica·2026

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Haematologica·2026

Related Experiment Videos

[Studies on antibody formation by L-asparaginase]

Related Concept Videos

Temporal trends and spatial distribution of research topics in anthropogenic marine debris study: Topic modelling using latent Dirichlet allocation.

MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression.

Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.

Surgical treatment outcomes of serious chronic tubo-ovarian abscess: a single-center series of 20 cases.

Pectic polysaccharides in carrot cells growing in suspension culture.

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[DDX41-mutated myeloid neoplasms].

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Related Experiment Videos

[Studies on antibody formation by L-asparaginase]

Related Concept Videos

Related Articles